Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen How who wrote (724)	2/21/1998 3:20:00 AM
From: Jim Roof	Read Replies (1) of 1432

This is what is known as a 'straw man' argument. One states what one hopes will be accepted as a premise in order to shoot it down. The fact is that shorts have been on this 'blood substitute' rag for quite a while now and when they pin that definition on Hextend then the rationale for a short interest is legitimate. The fact is that the short interest cannot argue against the efficacy of Hextend without either misrepresenting the nature of the product or misinterpreting the results of it. Period. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next